Literature DB >> 15288840

Proliferative verrucous vs conventional leukoplakia: no significantly increased risk of HPV infection.

G Campisi1, L Giovannelli, P Ammatuna, G Capra, G Colella, C Di Liberto, S Gandolfo, M Pentenero, M Carrozzo, R Serpico, M D'Angelo.   

Abstract

Proliferative verrucous leukoplakia (PVL) is a very aggressive form of oral leukoplakia (OL) with high morbidity and mortality rates, hypothesised to be linked to HPV infection. This study aimed to determine the presence of HPV DNA in PVL in comparison with OL, and in relation to social-demographical variables (age, gender, smoking and drinking habits) in an Italian multi-centric hospital-based study. The study group consisted of 58 cases of PVL and 90 cases of OL as controls (47 homogeneous (H) and 43 non-homogeneous (non-H) form), both recruited from four Italian cohorts. HPV DNA was identified in exfoliated mucosal cells by nested PCR (nPCR) with MY09/MY11 and GP5+/GP6+ primer pairs and the HPV genotype determined by direct DNA sequencing. HPV DNA was found in 24.1% (14/58)of PVL and in 25.5% (23/90) of OL; there was thus no significant difference found between PVL and OL (both forms) for risk of HPV infection (OR=0.93; 95% IC:0.432-1.985). Similarly, in both groups of PVL and OL lesions, no statistic association was found between any demographical variable considered and HPV infection. HPV-18 was the most frequently detected genotype in all tissues, being found in 78.5% and 60.8% of HPV+ve PVL and OL, respectively. Other more rarely detected genotypes were HPV-16 (28.6% in PVL and 13% in OL), HPV-6 (17.4% in OL) and HPV-53 (8.8% in OL). PVL does not appear more likely to be associated to HPV infection than conventional OL lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15288840     DOI: 10.1016/j.oraloncology.2004.02.007

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  A Retrospective 20-Year Analysis of Proliferative Verrucous Leukoplakia and Its Progression to Malignancy and Association with High-risk Human Papillomavirus.

Authors:  Jasbir D Upadhyaya; Sarah G Fitzpatrick; Mohammed N Islam; Indraneel Bhattacharyya; Donald M Cohen
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 2.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

Review 3.  Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners.

Authors:  K Staines; H Rogers
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

4.  Salivary and serum interleukin-6 levels in proliferative verrucous leukoplakia.

Authors:  Leticia Bagan; Guillermo T Sáez; M Carmen Tormos; Carlos Labaig-Rueda; Judith Murillo-Cortes; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2015-08-09       Impact factor: 3.573

5.  Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development.

Authors:  Carlos Llorens; Beatriz Soriano; Lucia Trilla-Fuertes; Leticia Bagan; Ricardo Ramos-Ruiz; Angelo Gamez-Pozo; Cristina Peña; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2020-09-11       Impact factor: 3.573

Review 6.  Role of human papillomavirus in oral squamous cell carcinoma and oral potentially malignant disorders: A review of the literature.

Authors:  Shikha Gupta; Sunita Gupta
Journal:  Indian J Dent       Date:  2015 Apr-Jun

7.  Low expression of angiotensinogen and dipeptidyl peptidase 1 in saliva of patients with proliferative verrucous leukoplakia.

Authors:  Isadora Luana Flores; Alan Roger Santos-Silva; Ricardo Della Coletta; Adriana Franco Paes Leme; Marcio Ajudarte Lopes
Journal:  World J Clin Cases       Date:  2016-11-16       Impact factor: 1.337

8.  High-Dose-Rate Brachytherapy for Primary Treatment of Refractory Proliferative Verrucous Leukoplakia of the Hard Palate.

Authors:  Jahan J Mohiuddin; Rabie M Shanti; Faizan Alawi; Brian M Chang; Jaclyn Marcel; Neil K Taunk; John N Lukens
Journal:  Cureus       Date:  2021-06-16

9.  Diode laser surgery in the treatment of oral proliferative verrucous leukoplakia associated with HPV-16 infection.

Authors:  Gian Paolo Bombeccari; Umberto Garagiola; Valentina Candotto; Francesco Pallotti; Francesco Carinci; Aldo Bruno Giannì; Francesco Spadari
Journal:  Maxillofac Plast Reconstr Surg       Date:  2018-07-30

Review 10.  Proliferative verrucous leukoplakia: diagnosis, management and current advances.

Authors:  Diogo Lenzi Capella; Jussara Maria Gonçalves; Adelino António Artur Abrantes; Liliane Janete Grando; Filipe Ivan Daniel
Journal:  Braz J Otorhinolaryngol       Date:  2017-01-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.